TY - CHAP AU - Sung-Jong Lee AU - Jin-Hwi Kim AU - Joo-Hee Yoon AU - Keun-Ho Lee AU - Dong- Choon Park AU - Chan-Joo Kim AU - Soo-Young Hur AU - Tae-Chul Park AU - Seog- Nyeon Bae AU - Jong-Sup Park ED - Maurie M. Markman Y1 - 2013-05-22 PY - 2013 T1 - Neoadjuvant Chemotherapy for Cervical Cancer: Rationale and Evolving Data N2 - In the chapters of this excellent text, the authors have described advances in the neoadjuvant chemotherapeutic management of a number of tumor types. Based on the extensive experience with this management concept in breast cancer, several chapters are devoted to this important topic (Section 1). Section 2 deals with the administration of neoadjuvant chemotherapy in non-breast malignancies. Those who read and study the content of the chapters in this book will come away with a far greater understanding of the rationale supporting neoadjuvant chemotherapy, the existing evidence-based data regarding its use, limitations of the approach, and required future investigative efforts to learn how to optimize the benefits of this innovative management concept. BT - Neoadjuvant Chemotherapy SP - Ch. 6 UR - https://doi.org/10.5772/53406 DO - 10.5772/53406 SN - PB - IntechOpen CY - Rijeka Y2 - 2024-03-28 ER -